OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: what do we know and future vistas
Roger S. McIntyre
Expert Opinion on Drug Safety (2024) Vol. 23, Iss. 5, pp. 539-542
Open Access | Times Cited: 16

Showing 16 citing articles:

The interface of depression and diabetes: treatment considerations
Giuseppe Fanelli, Emanuel Raschi, Gaye Hafez, et al.
Translational Psychiatry (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1

GLP-1 agonists and risk of suicidal thoughts and behaviours: Confound by indication once again? A narrative review
Robertas Strumila, Aistė Lengvenytė, Sebastien Guillaume, et al.
European Neuropsychopharmacology (2024) Vol. 87, pp. 29-34
Open Access | Times Cited: 7

Effects of GLP‐1 Receptor Agonists in Alcohol Use Disorder
Mette Kruse Klausen, Gitte M. Knudsen, Tina Vilsbøll, et al.
Basic & Clinical Pharmacology & Toxicology (2025) Vol. 136, Iss. 3
Open Access

The Effect of Glucagon-Like Peptide-1 Receptor Agonists on Measures of Suicidality A Systematic Review
Kyle Valentino, Kayla M. Teopiz, William W. L. Cheung, et al.
Journal of Psychiatric Research (2025) Vol. 183, pp. 112-126
Open Access

Suicide and Self-Harm Events With GLP-1 Receptor Agonists in Adults With Diabetes or Obesity
Pouya Ebrahimi, Juan C. Batlle, Aryan Ayati, et al.
JAMA Psychiatry (2025)
Closed Access

Glucagon-like peptide-1 receptor agonists for major neurocognitive disorders
Riccardo De Giorgi, Ana Ghenciulescu, Courtney Yotter, et al.
Journal of Neurology Neurosurgery & Psychiatry (2025), pp. jnnp-335593
Closed Access

A systematic review on the efficacy of GLP-1 receptor agonists in mitigating psychotropic drug-related weight gain
Trisha Menon, Serene M. L. Lee, Xiaowen Gong, et al.
CNS Spectrums (2024) Vol. 29, Iss. 5, pp. 347-353
Open Access | Times Cited: 2

Effects of ketamine on metabolic parameters in depressive disorders: A systematic review
Sabrina Wong, Gia Han Le, Rodrigo B. Mansur, et al.
Journal of Affective Disorders (2024) Vol. 367, pp. 164-173
Open Access | Times Cited: 1

A systematic review in effects of glucagon-like peptide-1 (GLP-1) mono-agonists on functional connectivity: Target engagement and rationale for the development in mental disorders
Hezekiah C T Au, Yang Jing Zheng, Gia Han Le, et al.
Journal of Affective Disorders (2024) Vol. 370, pp. 321-327
Closed Access | Times Cited: 1

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) as treatment for nicotine cessation in psychiatric populations: a systematic review
Serene M. L. Lee, Maggie Li, Gia Han Le, et al.
Annals of General Psychiatry (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 1

Increased reporting of accidental overdose with glucagon-like peptide-1 receptor agonists: a population-based study
Roger S. McIntyre, Angela T.H. Kwan
Expert Opinion on Drug Safety (2024), pp. 1-6
Closed Access | Times Cited: 1

Aripiprazole Augmentation as a Treatment for Clozapine-Induced Weight Gain: Response to Kramer and Velicu
Roger S. McIntyre, Angela T.H. Kwan, Joshua D. Rosenblat, et al.
American Journal of Psychiatry (2024) Vol. 181, Iss. 10, pp. 936-937
Closed Access

Page 1

Scroll to top